Showing results (71-80 of 247) with videos related to

Sort By:
Pageof 25
Molecular Genetics & Genomic Medicine|November 7, 2019
Identification of a novel somatic mutation of POU6F2 by whole-genome sequencing in prolactinomaYazhou Miao, Chuzhong Li, Jing Guo, et al.
International Journal of Molecular Medicine|January 8, 2021
CDKN2A (p16INK4A) affects the anti‑tumor effect of CDK inhibitor in somatotroph adenomasYiyuan Chen, Zhenye Li, Qiuyue Fang, et al.
Oncotargets and Therapy|December 20, 2021
High Red Cell Distribution Width Independently Predicts Adverse Survival in Patients with Newly Diagnosed Skull Base ChordomaMingxuan Li, Yutao Shen, Yujia Xiong, et al.
Frontiers in Oncology|October 31, 2022
High systemic inflammation score is associated with adverse survival in skull base chordomaMingxuan Li, Jiwei Bai, Yujia Xiong, et al.
International Journal of Endocrinology|June 22, 2019
Immunohistochemical Study of NR2C2, BTG2, TBX19, and CDK2 Expression in 31 Paired Primary/Recurrent Nonfunctioning Pituitary AdenomasXiaohui Yao, Yazhuo Zhang, Lijuan Wu, et al.
International Journal of Molecular Medicine|January 16, 2026
[Corrigendum] CDKN2A (p16INK4A) affects the anti‑tumor effect of CDK inhibitor in somatotroph adenomasYiyuan Chen, Zhenye Li, Qiuyue Fang, et al.
Biomed Research International|December 31, 2020
Clinical and Radiologic Characteristics, Surgical Outcomes, and Its Possible Origins of Chondroma of the Dural ConvexityJing Guo, Qiuyue Fang, Jianhua Cheng, et al.
The Journal of Craniofacial Surgery|February 17, 2022
The Clinical Features and Molecular Mechanism of Pituitary Adenoma Associated With Vestibular SchwannomaHaibo Zhu, Dawei Wang, Yazhou Miao, et al.
Pageof 25